Palbace 125 Mg

$1999$5700

Generic Brand Palbociclib
Strength 125 mg
Pharma Form Capsule/s
Manufacturer Pfizer Ltd
Treatment Breast cancer
Pack Size 21 Capsule/s, 42 Capsule/s, 63 Capsule/s

 

Pack Size
Choose an option
palbace 125 mg
Add to cart
Buy Now
Description

Product Description

Palbace 125 Mg

Palbace 125 mg Capsule is an anticancer drug use in combination with other medicines to treat certain types of breast cancer. Close monitoring of blood cell count is recommend during treatment with this medicine. This medicine is not recommend for use in patients below 18 years of age.

Side effects

  • Diarrhea
  • Nausea and Vomiting
  • Hair loss or thinning of the hair
  • Lack or loss of strength
  • Decrease in white blood cells and platelets
  • Anemia
  • Decreased appetite
  • Infections
  • Chills and fever
  • Rashes

How long does it take for this medicine to take effect?

The amount of time requir for this medicine to show its action is not clinically established.

How long do the effects of this medicine last?

The amount of time for which this medicine remains active in the body is not clinically establish.

Is it safe to consume alcohol while taking this medicine?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is this a habit forming medicine?

No habit-forming tendencies were reported.

Can this medicine be taken during pregnancy?

This medicine is not recommend for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

Can this medicine be taken while breast-feeding?

This medicine is not recommend for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

Disease interactions

Lung dysfunction

This medicine should use with extreme caution in patients with a history of lung dysfunction since it may worsen the patient’s condition. Close monitoring of lung function is recommend for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be requir based on the clinical condition.

Hepatic impairment

This medicine should use with caution in patients with liver function impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is recommend for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be requir in some cases based on the clinical condition.

Renal impairment

This medicine should use with caution in patients with severe renal impairment due to the increased risk of severe adverse effects. Close monitoring of renal function is recommend for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Additional information

Additional Information

Pack Size

21 Capsule/s, 42 Capsule/s, 63 Capsule/s